Complete response of gallbladder cancer treated with gemcitabine and cisplatin chemotherapy combined with durvalumab: A case report and review of literature

Figure 1 Multiphasic contrast-enhanced computed tomography findings. A: Gallbladder enlargement and wall thickening; B: Swollen hepatoduodenal mesenteric lymph nodes; C: A slightly lower density lesion.

Figure 2 Multiphasic contrast-enhanced computed tomography findings after 3 cycles of therapy. A: The shrunken hepatoduodenal mesenteric lymph nodes; B: The shrunken lower density lesion.

Figure 3 Multiphasic contrast-enhanced computed tomography findings after 6 months of therapy. A: The significantly shrunken hepatoduodenal mesenteric lymph nodes; B: The disappeared lower density lesion.

Figure 4 The timeline of the entire clinical course. GC-D: Gemcitabine, cisplatin, and durvalumab; PR: Partial response; CR: Complete response.